1002 related articles for article (PubMed ID: 19361507)
1. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis.
Gradel KO; Nielsen HL; Schønheyder HC; Ejlertsen T; Kristensen B; Nielsen H
Gastroenterology; 2009 Aug; 137(2):495-501. PubMed ID: 19361507
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of zoonotic Salmonella and Campylobacter gastroenteritis in patients with haematological malignancies: a population-based study.
Gradel KO; Nørgaard M; Dethlefsen C; Schønheyder HC; Kristensen B; Ejlertsen T; Nielsen H
Ann Hematol; 2009 Aug; 88(8):761-7. PubMed ID: 19083236
[TBL] [Abstract][Full Text] [Related]
3. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease.
García Rodríguez LA; Ruigómez A; Panés J
Gastroenterology; 2006 May; 130(6):1588-94. PubMed ID: 16697722
[TBL] [Abstract][Full Text] [Related]
4. Salmonella or Campylobacter gastroenteritis prior to a cancer diagnosis does not aggravate the prognosis: a population-based follow-up study.
Gradel KO; Nørgaard M; Schønheyder HC; Dethlefsen C; Ejlertsen T; Kristensen B; Nielsen H
APMIS; 2010 Feb; 118(2):136-42. PubMed ID: 20132177
[TBL] [Abstract][Full Text] [Related]
5. Psychological stress and inflammatory bowel disease: a follow-up study in parents who lost a child in Denmark.
Li J; Nørgard B; Precht DH; Olsen J
Am J Gastroenterol; 2004 Jun; 99(6):1129-33. PubMed ID: 15180736
[TBL] [Abstract][Full Text] [Related]
6. Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease.
Jess T; Simonsen J; Nielsen NM; Jørgensen KT; Bager P; Ethelberg S; Frisch M
Gut; 2011 Mar; 60(3):318-24. PubMed ID: 21193449
[TBL] [Abstract][Full Text] [Related]
7. Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities.
Ruigómez A; García Rodríguez LA; Panés J
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):465-9. PubMed ID: 17445753
[TBL] [Abstract][Full Text] [Related]
8. Morbidity and mortality of elderly patients with zoonotic Salmonella and Campylobacter: a population-based study.
Gradel KO; Schønheyder HC; Dethlefsen C; Kristensen B; Ejlertsen T; Nielsen H
J Infect; 2008 Sep; 57(3):214-22. PubMed ID: 18656265
[TBL] [Abstract][Full Text] [Related]
9. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Wajda A; Blanchard JF
Clin Gastroenterol Hepatol; 2008 Jan; 6(1):41-5. PubMed ID: 18063423
[TBL] [Abstract][Full Text] [Related]
10. Are host characteristics or exposure factors mainly involved in the acquisition of zoonotic Salmonella and Campylobacter coinfection in humans?
Gradel KO; Schønheyder HC; Kristensen B; Dethlefsen C; Ejlertsen T; Nielsen H
Foodborne Pathog Dis; 2009 Mar; 6(2):251-5. PubMed ID: 19099355
[TBL] [Abstract][Full Text] [Related]
11. Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study.
Bernstein CN; Nugent Z; Longobardi T; Blanchard JF
Am J Gastroenterol; 2009 Nov; 104(11):2774-8. PubMed ID: 19623167
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study.
Munk EM; Pedersen L; Floyd A; Nørgård B; Rasmussen HH; Sørensen HT
Am J Gastroenterol; 2004 May; 99(5):884-8. PubMed ID: 15128355
[TBL] [Abstract][Full Text] [Related]
13. Risk of arterial thrombotic events in inflammatory bowel disease.
Ha C; Magowan S; Accortt NA; Chen J; Stone CD
Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
[TBL] [Abstract][Full Text] [Related]
14. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
[TBL] [Abstract][Full Text] [Related]
15. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
[TBL] [Abstract][Full Text] [Related]
16. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission.
Clayton EM; Rea MC; Shanahan F; Quigley EM; Kiely B; Hill C; Ross RP
Am J Gastroenterol; 2009 May; 104(5):1162-9. PubMed ID: 19319128
[TBL] [Abstract][Full Text] [Related]
17. Impact of Clostridium difficile on inflammatory bowel disease.
Issa M; Vijayapal A; Graham MB; Beaulieu DB; Otterson MF; Lundeen S; Skaros S; Weber LR; Komorowski RA; Knox JF; Emmons J; Bajaj JS; Binion DG
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):345-51. PubMed ID: 17368234
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.
Söderlund S; Granath F; Broström O; Karlén P; Löfberg R; Ekbom A; Askling J
Gastroenterology; 2010 May; 138(5):1697-703. PubMed ID: 20167217
[TBL] [Abstract][Full Text] [Related]
19. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
20. Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
Gupta G; Gelfand JM; Lewis JD
Gastroenterology; 2005 Sep; 129(3):819-26. PubMed ID: 16143121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
